{
    "Trade/Device Name(s)": [
        "Liquichek Diabetes Control"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K123798",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052838"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "January 9, 2013",
    "Summary Letter Received Date": "December 10, 2012",
    "Submission Date": "December 7, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1C"
    ],
    "Specimen Type(s)": [
        "Human whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Liquichek Diabetes Control, a liquid human whole blood-based quality control material for Hemoglobin A1C monitoring in clinical laboratories",
    "Indications for Use Summary": "Intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for the analyte listed in the package insert",
    "fda_folder": "Clinical Chemistry"
}